Clinical Trial Update: Study of ENP-501 in Peanut-Allergic and Non-Allergic Participants [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 study of ENP-501 in peanut-allergic and non-allergic participants is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peanut Allergy

Drugs mentioned

• ENP-501

Snippet

Sponsor: N-Fold, LLC | Conditions: Peanut Allergy | Phase 1, Phase 2 | Status: RECRUITING